2021/2678(RSP)
EU transparency in the development, purchase and distribution of COVID-19 vaccines
EU transparency in the development, purchase and distribution of COVID-19 vaccines
At a glance
Source and coverage
- Source last checked
- 28/08/2026, 06:01:26
- Record current through
- 24/08/2026
- Institution
- European Union / European Parliament
- Parliamentary term
- Depends on procedure timeline
Coverage limitations: Linked votes are only those for which the ingestion source supplies a reliable procedure relationship. Absence here is not proof that no related parliamentary activity occurred.
Read reporting and briefings ↗
- Procedure
- RSP
- Status
- In progress / not supplied
- Primary record
- Legislative Observatory ↗
Linked roll-call votes
Amendments and procedural votes are shown alongside the main/final vote when recorded.
- 2021-10-21main voteEU transparency in the development, purchase and distribution of COVID-19 vaccines
458 for · 149 against
- 2021-10-20EU transparency in the development, purchase and distribution of COVID-19 vaccines
138 for · 549 against
- 2021-10-20EU transparency in the development, purchase and distribution of COVID-19 vaccines
130 for · 553 against
- 2021-10-20EU transparency in the development, purchase and distribution of COVID-19 vaccines
116 for · 537 against
- 2021-10-20EU transparency in the development, purchase and distribution of COVID-19 vaccines
127 for · 555 against
- 2021-10-20EU transparency in the development, purchase and distribution of COVID-19 vaccines
314 for · 368 against
- 2021-10-20EU transparency in the development, purchase and distribution of COVID-19 vaccines
248 for · 417 against
- 2021-10-20EU transparency in the development, purchase and distribution of COVID-19 vaccines
210 for · 430 against
- 2021-10-20EU transparency in the development, purchase and distribution of COVID-19 vaccines
286 for · 397 against
- 2021-10-20EU transparency in the development, purchase and distribution of COVID-19 vaccines
403 for · 269 against
- 2021-10-20EU transparency in the development, purchase and distribution of COVID-19 vaccines
233 for · 423 against
- 2021-10-20EU transparency in the development, purchase and distribution of COVID-19 vaccines
101 for · 545 against
- 2021-10-20EU transparency in the development, purchase and distribution of COVID-19 vaccines
289 for · 389 against
- 2021-10-20EU transparency in the development, purchase and distribution of COVID-19 vaccines
356 for · 281 against
- 2021-10-20EU transparency in the development, purchase and distribution of COVID-19 vaccines
207 for · 429 against
- 2021-10-20EU transparency in the development, purchase and distribution of COVID-19 vaccines
236 for · 419 against
- 2021-10-20EU transparency in the development, purchase and distribution of COVID-19 vaccines
246 for · 415 against
- 2021-10-20EU transparency in the development, purchase and distribution of COVID-19 vaccines
111 for · 574 against
- 2021-10-20EU transparency in the development, purchase and distribution of COVID-19 vaccines
286 for · 375 against
- 2021-10-20EU transparency in the development, purchase and distribution of COVID-19 vaccines
146 for · 539 against
- 2021-10-20EU transparency in the development, purchase and distribution of COVID-19 vaccines
252 for · 411 against
- 2021-10-20EU transparency in the development, purchase and distribution of COVID-19 vaccines
119 for · 546 against
- 2021-10-20EU transparency in the development, purchase and distribution of COVID-19 vaccines
500 for · 191 against
- 2021-10-20EU transparency in the development, purchase and distribution of COVID-19 vaccines
676 for · 12 against
- 2021-10-20EU transparency in the development, purchase and distribution of COVID-19 vaccines
467 for · 193 against
- 2021-10-20EU transparency in the development, purchase and distribution of COVID-19 vaccines
632 for · 50 against
- 2021-10-20EU transparency in the development, purchase and distribution of COVID-19 vaccines
397 for · 256 against
- 2021-10-20EU transparency in the development, purchase and distribution of COVID-19 vaccines
500 for · 192 against
- 2021-10-20EU transparency in the development, purchase and distribution of COVID-19 vaccines
674 for · 8 against
- 2021-10-20EU transparency in the development, purchase and distribution of COVID-19 vaccines
488 for · 197 against